Therefore, aiming to have novel options for future treatment of CESC, it is essential to deeply investigate the synergistic mechanisms between ALKBH5 and reader proteins underlying the CESC metabolic reprogramming. The gene discussed is ALKBH5; the disease is cervical squamous cell carcinoma.